lecture 01.2014
TRANSCRIPT
MBSM 713: BIOCHEMISTRY OF ANTI MICROBIAL AGENTS
Lecture one
Dr. G. Kattam Maiyoh
01/23/15 1GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
Importance of Microbes
• Life is microbial! (to the first approximation)– Micro-organisms colonise every
environment on earth– >80% of life’s history was bacterial
– You have more bacterial cells than human cells (10x more)
– Microbes play a key role in the biosphere
– Pathogenic microbes globally are the most important cause of human disease and death
01/23/15 2GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Importance of Infection• Has played a decisive role in history• Still major cause of death and misery worldwide• Examples of public anxieties
– Meningitis, Food poisoning– Mad cow disease– HIV
– Cholera– Emerging infections e.g. Ebola, swine flu– Hospital Infection (Nosocomial infections)
• Antibiotic-Resistant Superbugs
01/23/15 3GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
What are Antimicrobials???• Antimicrobials are drugs that destroy microbes,
prevent their multiplication or growth, or prevent their pathogenic action
– Differ in their physical, chemical, and pharmacological properties
– Differ in antimicrobial spectrum of activity
– Differ in their mechanism of action
01/23/15 4GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
• It is chosen so that it kills the desired microbes only, but not the cells in your (host) body.
• Each different type of antibiotic affects different bacteria in different ways.
• For example, an antimicrobial might inhibit a microbe’s ability to turn glucose into energy, or its ability to construct its cell wall.
• Therefore the microbe dies instead of reproducing.
01/23/15 5GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
It is a selective poison
Classification of Antimicrobials
• Based against the target organism– Antibacterial (antibiotics)– Antifungal– Antiviral– Antiprotozoan– Antihelminthics
01/23/15 6GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
History of Antimicrobials
• Mostly on antibiotics• (anti, "against"; bios, "life") An antibiotic is a
chemical substance produced by one organism that is destructive to another.
• The word antibiotic came from the word antibiosis a term coined in 1889 by Louis Pasteur's student Paul Vuillemin which means a process by which life could be used to destroy life.
01/23/15 7GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Ancient History• The ancient Egyptians, the Chinese, and
Indians of central America all used molds to treat infected wounds.
• However, they did not understand the connection of the antibacterial properties of mold and the treatment of diseases.
Mould
01/23/15 8GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Late 1800s• The search for antibiotics began in the late
1800s, with the growing acceptance of the germ theory of disease, a theory which linked bacteria and other microbes to the causation of a variety of ailments.
• As a result, scientists began to devote time to searching for drugs that would kill these disease-causing bacteria.
01/23/15 9GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
1871• The surgeon Joseph Lister, began researching the
phenomenon that urine contaminated with mold would not allow the successful growth of bacteria.
1890s• German doctors, Rudolf Emmerich and Oscar Low were
the first to make an effective medication that they called pyocyanase from microbes.
• It was the first antibiotic to be used in hospitals. However, the drug often did not work
• Learning check – why do you think the drug did not work some of the time?
01/23/15 10GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
1928: Fleming and Penicillin
Sir Alexander Fleming observed that colonies of the bacterium Staphylococcus aureus could be destroyed by the mold Penicillium notatum, demonstrating antibacterial properties.
01/23/15 11GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
1935- the first sulfa drug discovered
•German pathologist and bacteriologist Credited with the discovery of Sulfonamidochrysoidine (KI-730) – the first commercially available antibacterial antibiotic (marketed under the brand name Prontosil)
•1939 Nobel Prize in Physiology/ Medicine
Gerhard Domagk (1895–1964).
01/23/15 13GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
•1940 – Howard Florey and Ernst Chain performed first clinical trials of penicillin.
•1942•Invented manufacturing process for Penicillin G Procaine.
•Penicillin could now be sold as a drug.
•Fleming, Florey, and Chain shared the 1945 Nobel Prize for medicine for their work on penicillin.
Howard Florey (1898–1968)
01/23/15 14GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Penicillin in summary• Penicillin was isolated in 1939.
• Concerted effort by a number of scientists;
• Originally noticed by a French medical student, Ernest Duchesne, in 1896
• Re-discovered by bacteriologist Alexander Fleming – Published investigations in 1929
• Dorothy discoved the molecular layout of penicillin – used x-rays
• 1939 Dr. Howard Florey demonstrate penicillin's ability to kill infectious bacteria.
• 1940_____________________________• 1942 _____________________________
01/23/15 15GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
1943•American microbiologist made the drug streptomycin from soil bacteria, the first of a new class of drugs called aminoglycosides.
•Streptomycin could treat diseases like tuberculosis, however;•The side effects were often too severe.
Selman Waksman (1888–1973)
01/23/15 16GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
1955Tetracycline was patented by Lloyd Conover, which became the most prescribed broad spectrum antibiotic in the United States.
1957•Nystatin was patented and used to cure many disfiguring and disabling fungal infections.
•Invented by Elizabeth Lee Hazen and Rachel Fuller Brown
•Researchers for the New York Department of Health
01/23/15 17GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
1981
•SmithKline Beecham patented Amoxicillin or moxicillin/clavulanate potassium tablets.
•First sold the antibiotic in 1998 under the trade names of Amoxicillin, Amoxil, and Trimox.
•Amoxicillin is a semisynthetic antibiotic.
01/23/15 18GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Definitions• Chemotherapy The use of drugs to treat a
disease
• Antimicrobial drugs Interfere with the growth of microbes within a host
• Antibiotic Substance produced by a microbe that, in small amounts, inhibits another microbe
• Selective toxicity A drug’s ability to kills harmful microbes without damaging the host
• Bacteriostatic/ Modes of action that either kill or
bacteriocidal inhibit growth of bacteria
• Spectrum of activity Range of effect within or between groups of microbes; narrow vs. broad-spectrum01/23/15 19GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
Static vs. Cidal•The graphs show the growth curves for a
bacterium treated with two drugs.
•The upper curve shows the activity of a
bacteriostatic drug.
•The bacterial growth resumes when the
drug is withdrawn.
•The cidal drug, shown in the lower graph,
kills bacteria from the time of administration
to the culture.
• Penicillins, aminoglycoside, vanconmycin, bacitracin , the polymyxin, and colistin are bactericidal.
• Tetracyline , Fusidic acid , Macrolides, Sulfonamides and sulfones on the other hand, are bacteriostatic.
01/23/15 20GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Classification of Antibiotics
• Bacteriostatic vs. Bactericidal
01/23/15 21GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Principles of antimicrobial use!
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
22
1. Identification of the Infective Organisms1. Identification of the Infective Organisms
History taking
Physical examination
Laboratory
01/23/15 23GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
History TakingHistory Taking
• Duration of fever
• Associated symptoms: Systematic review
• History of treatment
• Underlying diseases and Medication
• Occupation• Living place
• Traveling• Pets• Vaccination
and drug prophylaxis
• Illness in family
• Diseases outbreak
• Food consumption
01/23/15 24GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Physical ExaminationPhysical Examination
01/23/15 25GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Physical ExaminationPhysical Examination
01/23/15 26GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Laboratory Investigation in the Diagnosis of Infectious AgentsLaboratory Investigation in the Diagnosis of Infectious Agents
Mandell, Douglas, and Bennett’s Principle and Practice of Infectious Diseases01/23/15 27GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
2) Antimicrobial susceptibility
– Appropriate specimen collection and transport
– Disk diffusion susceptibility testing– Minimal inhibitory
concentration (MIC)
01/23/15 28GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Underlying diseasesDrug allergyPregnancy/Breast feedingAgeGenetic or Metabolic abnormalitiesSites of infectionImmune statusHepatic and renal function
3) Determine host Factors3) Determine host Factors
01/23/15 29GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
4) Antimicrobial Factors4) Antimicrobial Factors
Spectrum
Mechanisms of action
Pharmacokinetic
Pharmacodynamic
Drug interaction
Side effect
Drug monitoring
01/23/15 30GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Indications for Antimicrobial Indications for Antimicrobial Combinations TherapyCombinations Therapy
Prevention of the emergence of resistant organisms
Polymicrobial infections
Empirical therapy
As narrow as possible, as broad as necessary
Synergistic/Additive activity01/23/15 31GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
Disadvantages of Inappropriate Use of Disadvantages of Inappropriate Use of Antimicrobial CombinationsAntimicrobial Combinations
Antagonism
Superinfection
Cost
Adverse effects
01/23/15 32GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Reasons for Treatment FailureReasons for Treatment Failure
Delay in diagnosis or therapyWrong or incomplete diagnosis
No infectionNonbacterial infection (for antibiotics)Polymicrobial infection
Errors in susceptibility testingDecreased activity at site of infection
Chemical factor (pH and others)Antibiotic antagonism
01/23/15 33GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Inadequate concentration of antibiotic at the site of infection
Improper doseDecreased absorption from food or drug interactionIncreased elimination of agentHigh protein bindingPoor delivery (eg. shock, vascular diseases)
Reasons for Treatment FailureReasons for Treatment Failure
01/23/15 34GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Reasons for Treatment FailureReasons for Treatment Failure
Impaired immune defensesDevelopment of drug resistanceSuperinfectionOther host factors
Necrotic tissueForeign body
01/23/15 35GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
A major cause of antimicrobial overuse is “treatment”
of contaminated cultures or colonization.
Use Antimicrobials WiselyUse Antimicrobials Wisely
Treat infection, NOT contamination or colonization
Use local dataKnow your local antibiogramKnow your patient population
Not all infections need antimicrobial therapyhttp://www.cdc.gov
01/23/15 36GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
• When infection is cured
• When cultures are negative and infection is unlikely
• When infection is not diagnosed
Use Antimicrobials Use Antimicrobials WiselyWisely Stop antimicrobial treatment
http://www.cdc.gov01/23/15 37GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
Mechanisms of Action of Antibacterials
– Protein synthesis inhibitors
– Cell wall synthesis inhibitors
– Plasma membrane-injuring agents
– Nucleic acid inhibitors
– Metabolic/enzyme inhibitors
01/23/15 38GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
The Action of Antimicrobial Drugs
Figure 20.201/23/15 39GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
Protein Synthesis Inhibitors
Figure 20.401/23/15 40GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
The Action of Antimicrobial Drugs
Figure 20.201/23/15 41GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
• Penicillins– Natural penicillins: G, V
– Semisynthetic penicillins• “-cillin “ suffix• Carbapenems• Monobactam
Antibacterial Antibiotics Inhibitors of Cell Wall Synthesis: e.g Penicilins
01/23/15 42GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Penicillins
Figure 20.601/23/15 43GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
• Cephalosporins– 2nd, 3rd, and 4th
generations more effective against gram-negatives
Antibacterial Antibiotics Inhibitors of Cell Wall Synthesis: Cephalosporins
Figure 20.901/23/15 44GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
• Polypeptide antibiotics– Bacitracin
• Topical application
• Against gram-positives
– Vancomycin• Glycopeptide• Important "last line"
against antibiotic resistant S. aureus (e.g. MRSA)
Antibacterial Antibiotics Inhibitors of Cell Wall Synthesis: Polypeptides
01/23/15 45GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
• Antimycobacterium antibiotics– Isoniazid (INH)
• Inhibits mycolic acid synthesis
– Ethambutol• Inhibits incorporation of mycolic acid
Antibacterial Antibiotics Inhibitors of Cell Wall Synthesis: Anti-Mycobacterials
01/23/15 46GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
The Action of Antimicrobial Drugs
Figure 20.201/23/15 47GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
• Polymyxin B– Topical– Combined with bacitracin and neomycin in over-
the-counter preparation
Antibacterial Antibiotics Injury to the Plasma Membrane
01/23/15 48GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
The Action of Antimicrobial Drugs
Figure 20.201/23/15 49GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
• Rifamycin– Inhibits RNA synthesis by RNA polymerase– Antituberculosis
• Quinolones and fluoroquinolones– Ciprofloxacin– Inhibits DNA gyrase so blocks DNA polymerase– Urinary tract infections
Antibacterial Antibiotics Inhibitors of Nucleic Acid Synthesis
01/23/15 50GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
The Action of Antimicrobial Drugs
Figure 20.201/23/15 51GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
– Sulfonamides (Sulfa drugs)• Inhibit folic acid synthesis• Broad spectrum
Antibacterial Antibiotics Competitive Inhibitors
Figure 5.701/23/15 52GKM/KISIIU/MBSM713
/BIOC.AMIC.AGENS.LEC01
Figure 20.13
TMZ - Trimethoprim + Sulfamethoxazole: Synergism
01/23/15 53GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
Thank for your attention
01/23/15 GKM/KISIIU/MBSM713 /BIOC.AMIC.AGENS.LEC01
54